Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/circulating-tumor-dna-guided-adjuvant-therapy-cuts-bladder-2026a1000amx?src=rss
Author :
Publish date : 2026-04-08 05:46:00
Copyright for syndicated content belongs to the linked Source.
